Analysts have been eager to weigh in on the Healthcare sector with new ratings on Thermo Fisher (TMO – Research Report), Biogen (BIIB – Research Report) and Molina Healthcare (MOH – Research Report).
Thermo Fisher (TMO)
In a report released yesterday, Michael Ryskin from Bank of America Securities reiterated a Buy rating on Thermo Fisher, with a price target of $600.00. The company’s shares closed last Wednesday at $577.39, close to its 52-week high of $603.82.
According to TipRanks.com, Ryskin is a 3-star analyst with an average return of
Thermo Fisher has an analyst consensus of Strong Buy, with a price target consensus of $617.00, implying a 6.7% upside from current levels. In a report issued on April 10, Goldman Sachs also maintained a Buy rating on the stock with a $640.00 price target.
See today’s best-performing stocks on TipRanks >>
Biogen (BIIB)
In a report released yesterday, Mohit Bansal from Wells Fargo maintained a Hold rating on Biogen, with a price target of $240.00. The company’s shares closed last Wednesday at $201.99, close to its 52-week low of $189.44.
According to TipRanks.com, Bansal is a 4-star analyst with an average return of
Currently, the analyst consensus on Biogen is a Moderate Buy with an average price target of $283.95, which is a 42.7% upside from current levels. In a report issued on April 11, J.P. Morgan also maintained a Hold rating on the stock with a $240.00 price target.
Molina Healthcare (MOH)
In a report released yesterday, Steve Baxter from Wells Fargo maintained a Hold rating on Molina Healthcare, with a price target of $410.00. The company’s shares closed last Wednesday at $367.41.
According to TipRanks.com, Baxter is a 3-star analyst with an average return of
Molina Healthcare has an analyst consensus of Moderate Buy, with a price target consensus of $416.11, implying a 14.2% upside from current levels. In a report issued on April 15, Barclays also maintained a Hold rating on the stock with a $437.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on TMO:
